Synergistic blend combining BPC-157 (VEGFR2/NO/FAK pathways) and TB-500 (actin regulation/progenitor cell mobilization) for multi-pathway tissue repair research. ≥98% supplier batch specification per component; selected lots independently tested (99.4% avg across published reports). For laboratory research use only.
| Name | BPC-157 + TB-500 Blend |
| Size | 4mg |
| SKU | CP-BB4 |
| Form | Lyophilized powder |
| Category | Tissue Healing and Regeneration Research Compounds |
| Storage | -20°C lyophilized · 2–8°C reconstituted |
Research-grade Klow Blend (BPC-157 + GHK-Cu + TB-500 + KPV). ≥98% supplier batch specification; selected lots independently tested (99.4% avg across published reports). Lyophilized
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied for its immunomodulat
Three-peptide co-lyophilized research blend: BPC-157 + GHK-Cu + TB-500 in a single 70mg vial. Targets angiogenesis, cell migration, and extracellular matrix renewal simultaneously.
Research-grade Ara-290. ≥98% supplier batch specification; selected lots independently tested (99.4% avg across published reports). Lyophilized powder in sealed glass vial. For lab